Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.
Le Cesne A, Blay JY, Domont J, Tresch-Bruneel E, Chevreau C, Bertucci F, Delcambre C, Saada-Bouzid E, Piperno-Neumann S, Bay JO, Mir O, Ray-Coquard I, Ryckewaert T, Valentin T, Isambert N, Italiano A, Clisant S, Penel N. Le Cesne A, et al. Among authors: valentin t. Lancet Oncol. 2015 Mar;16(3):312-9. doi: 10.1016/S1470-2045(15)70031-8. Epub 2015 Feb 11. Lancet Oncol. 2015. PMID: 25680558 Clinical Trial.
Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
Gaspard M, Lamant L, Tournier E, Valentin T, Rochaix P, Terrier P, Ranchere-Vince D, Coindre JM, Filleron T, Le Guellec S. Gaspard M, et al. Among authors: valentin t. Histopathology. 2018 Dec;73(6):969-982. doi: 10.1111/his.13740. Epub 2018 Oct 23. Histopathology. 2018. PMID: 30137667
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T, Le Guellec S, Chevreau C, Cabarrou B, Lesluyes T, Lodin S, Massoubre A, Mounier M, Poublanc M, Chibon F, Valentin T. Filleron T, et al. Among authors: valentin t. BMC Cancer. 2020 Jul 31;20(1):716. doi: 10.1186/s12885-020-07207-3. BMC Cancer. 2020. PMID: 32736540 Free PMC article.
Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma.
Dufresne A, Lesluyes T, Ménétrier-Caux C, Brahmi M, Darbo E, Toulmonde M, Italiano A, Mir O, Le Cesne A, Le Guellec S, Valentin T, Chevreau C, Bonvalot S, Robin YM, Coindre JM, Caux C, Blay JY, Chibon F. Dufresne A, et al. Among authors: valentin t. Oncoimmunology. 2020 Jul 12;9(1):1792036. doi: 10.1080/2162402X.2020.1792036. Oncoimmunology. 2020. PMID: 32923153 Free PMC article.
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
Brahmi M, Lesluyes T, Dufresne A, Toulmonde M, Italiano A, Mir O, Le Cesne A, Valentin T, Chevreau C, Bonvalot S, Penel N, Coindre JM, Le Guellec S, Le Loarer F, Karanian M, Blay JY, Chibon F. Brahmi M, et al. Among authors: valentin t. ESMO Open. 2021 Feb;6(1):100037. doi: 10.1016/j.esmoop.2020.100037. Epub 2021 Jan 29. ESMO Open. 2021. PMID: 33524869 Free PMC article.
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment.
Attal J, Cabarrou B, Valentin T, Nesseler JP, Stoeckle E, Ducassou A, Filleron T, Le Guellec S, Boulet B, Vogin G, Ferron G, Moyal EC, Delannes M, Chevreau C. Attal J, et al. Among authors: valentin t. Strahlenther Onkol. 2021 Dec;197(12):1051-1062. doi: 10.1007/s00066-021-01847-5. Epub 2021 Oct 21. Strahlenther Onkol. 2021. PMID: 34673991
147 results